Catalyst Biosciences Raises $40M from Boston-Area Backers and Other Firms

Cambridge, MA-based venture firm HealthCare Ventures and several other backers have invested $40.4 million in a Series C round of financing for Catalyst Biosciences, a South San Francisco developer of protein-based drugs for diseases such as hemophilia and cancer, according to a company statement. Morgenthaler Ventures, a Menlo Park, CA-based firm which says it has a Boston office, and Novartis BioVentures, of Cambridge and Basel, Switzerland, are among the other firms that participated in the financing.

Trending on Xconomy